Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Acute Myeloid Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05488132
What this trial is testing

Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
Xuzhou Medical University 20
Early research (Phase 1)Study completedNCT01396499
What this trial is testing

Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 16
Large-scale testing (Phase 3)UnknownNCT04722952
What this trial is testing

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

Who this might be right for
ImmunotherapyRefractory LeukemiaRelapsed Adult AML+1 more
The First Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)Ended earlyNCT00818649
What this trial is testing

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 16
Testing effectiveness (Phase 2)UnknownNCT05821738
What this trial is testing

Avapritinib in CBF-AML With KIT Mutations

Who this might be right for
Core Binding Factor Acute Myeloid LeukemiaKIT Mutation-Related Tumors
The First Affiliated Hospital of Soochow University 50
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Early research (Phase 1)Study completedNCT03298516
What this trial is testing

DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Genentech, Inc. 19
Very early researchUnknownNCT06541444
What this trial is testing

Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
Base Therapeutics (Shanghai) Co., Ltd. 9
Testing effectiveness (Phase 2)Study completedNCT00766116
What this trial is testing

Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
University of California, San Diego 50
Early research (Phase 1)Looking for participantsNCT05105152
What this trial is testing

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
Seattle Children's Hospital 18
Early research (Phase 1)Ended earlyNCT04310592
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults with AML

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myeloid, Acute+17 more
Celularity Incorporated 27
Testing effectiveness (Phase 2)Study completedNCT00806767
What this trial is testing

Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Institut Paoli-Calmettes 82
Testing effectiveness (Phase 2)Ended earlyNCT03067571
What this trial is testing

Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
High Risk Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center 7
Not applicableStudy completedNCT00376922
What this trial is testing

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Wake Forest University Health Sciences 65
Early research (Phase 1)Looking for participantsNCT04771572
What this trial is testing

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Who this might be right for
Non Hodgkin LymphomaRichter TransformationMultiple Myeloma+10 more
Newave Pharmaceutical Inc 100
Early research (Phase 1)Study completedNCT00900809
What this trial is testing

QUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
ImmunityBio, Inc. 7
Testing effectiveness (Phase 2)Ended earlyNCT04113616
What this trial is testing

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)
Kartos Therapeutics, Inc. 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07575412
What this trial is testing

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more
The First Affiliated Hospital of Soochow University 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT01686334
What this trial is testing

Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia
Zwi Berneman 130
Next Page